Latest Breaking News On - Atamyo therapeutics - Page 1 : comparemela.com

Atamyo Therapeutics to Start Limb-Girdle Muscular Dystrophy Gene Therapy Trial in Italy, France

Atamyo Therapeutics to Start Limb-Girdle Muscular Dystrophy Gene Therapy Trial in Italy, France
precisionmedicineonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from precisionmedicineonline.com Daily Mail and Mail on Sunday newspapers.

French medicines agencyItalian medicines agencyAtamyo therapeutics

Genethon Pursues Different Strategies for Ensuring Patient Access to Gene Therapies for Rare Diseases

Genethon Pursues Different Strategies for Ensuring Patient Access to Gene Therapies for Rare Diseases
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomCharles craigCrigler najjarStephane degoveIsabelle richardFrederic revahGenethon progressive dystrophies laboratoryOpus biotech communicationsInternational rare disease dayDrug administrationAtamyo coAtamyo therapeuticsProgressive dystrophies laboratoryChief scientific officerProgressive muscular dystrophies team

Gene therapy for rare muscular dystrophy presents promise

Gene therapy for rare muscular dystrophy presents promise
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

United kingdomJohn vissingSophie olivierInternational limbDrug administrationEuropean society of gene cell therapyAtamyo therapeuticsEuropean societyCell therapyLimb girdle muscular dystrophyChief medicalData safety monitoring boardInvestigational new drug

Atamyo Therapeutics Cleared to Begin Limb-Girdle Muscular Dystrophy Gene Therapy Trial in US

The one-time gene therapy is designed to deliver a normal copy of the gene perturbed in LGMD type 2I/R9.

United kingdomSophie olivierDrug administrationAtamyo therapeuticsChief medical officer sophie olivierFrance based atamyo

Gene Therapy Pioneer Roger Hajjar, MD, Joins Atamyo Therapeutics Board of Directors

Atamyo Therapeutics, a biotechnology company focused on the development of new-generation gene therapies targeting muscular dystrophies and cardiomyopathies, today announced the appointment of Roger J. Hajjar, MD,

New yorkUnited statesFrederic revahStephane degoveRogerj hajjarHarvard medical schoolDivision of health sciences technologyCell therapy institute at massAtamyo therapeuticsCell therapy instituteMass general brighamHealth sciencesMassachusetts general hospitalCardiovascular research centerIcahn schoolMount sinai